Remarks will highlight the latest deep learning technology from Deep Genomics for
discovering RNA disease mechanisms and candidate therapeutics
TORONTO--(BUSINESS WIRE)--September 20, 2023 Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its founder and Chief Innovation Officer, Brendan Frey, Ph.D., F.R.S.C., will present at the 2023 Elevate Festival in Toronto on Tuesday, September 26, 2022, at 6:35 PM EST.
Brendan’s remarks, titled Beacons of Hope: AI in Medicine will highlight recent advances in the use of Artificial Intelligence (AI) and deep learning for drug discovery. As the inventor of one of the first deep learning algorithms that helped to catapult the field forward, Brendan’s contributions to the field of AI are used in thousands of products around the world. The past three years have seen major breakthroughs in AI technology, showing promise for advances in the life sciences. Accurate predictions can now be made on how the genetics of patients can negatively alter gene expression and how molecules can provide therapeutic benefits. Brendan will share his perspective on opportunities for AI in RNA therapeutics and highlight a new innovation from the Deep Genomics team, BigRNA, that goes far beyond traditional missense variant effects, and has the potential to transform the discovery and development of RNA therapeutics.
About Elevate Festival:
Elevate Festival is Canada’s largest homegrown tech and innovation festival uniting world-class innovators and industry leaders who are building a better future. Featuring world-class speakers, ecosystem socials, opportunities to grow your business, and a space to find your people. Elevate is a non-profit that unites the world’s innovators to solve society’s greatest challenges. Through its annual Elevate festival and diversity-driven programs for startup founders, the organization spotlights Canadian innovation while bringing about meaningful change at home and on the global stage. Elevate has hosted global icons such as First Lady & Author Michelle Obama, Businesswoman & TV personality Martha Stewart, Tennis Champ & Entrepreneur Venus Williams, Former Google CEO Eric Schmidt, and U.S. Vice President Al Gore, each of whom have inspired millions of people. Learn more at Elevate.ca..
About Deep Genomics
Deep Genomics is a biopharmaceutical company that aims to revolutionize drug development by leveraging expertise in artificial intelligence (AI) to decode RNA biology. Our proprietary platform, the AI Workbench, enables us to decode the enormous complexity of RNA biology to find novel targets, mechanisms, and molecules that are not accessible through traditional methods. We use this advanced technology to develop steric-blocking oligonucleotides (SBOs) that achieve expression increase for the treatment of genetic disease. Founded in 2015, our multidisciplinary team includes expertise in a diverse range of disciplines including those found in a traditional drug company, as well as machine learning, laboratory automation, and software engineering. Deep Genomics is located in Toronto, Ontario and Cambridge, Massachusetts. For more information, visit: www.deepgenomics.com and follow us on LinkedIn and Twitter.
Media Contact:
Maureen L. Suda
Suda Communications LLC
585-355-1134
maureensuda@gmail.com